{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:48:01Z","timestamp":1773920881574,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RGP-212"],"award-info":[{"award-number":["RGP-212"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejps.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T02:13:17Z","timestamp":1523412797000},"page":"171-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5955-3783","authenticated-orcid":false,"given":"Azmat Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer M.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mumtaz","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahanavaj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.04.015_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4155\/tde.11.30","article-title":"Beaded plasma clot, a potent sustained-release drug-delivery system","volume":"2","author":"Ahmad","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2018.04.015_bb0010","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","article-title":"Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis","volume":"44","author":"Arthington-Skaggs","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0015","first-page":"1111","article-title":"Porous microsphere and its applications","volume":"8","author":"Cai","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.04.015_bb0020","first-page":"3527","article-title":"Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes","volume":"9","author":"Cai","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.04.015_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003088-199324010-00002","article-title":"Clinical pharmacokinetics of fluconazole","volume":"24","author":"Debruyne","year":"1993","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejps.2018.04.015_bb0030","series-title":"High-dose Therapy With Fluconazole \u2265800\u202fmg\u202fday\u22121","author":"Duswald","year":"1997"},{"key":"10.1016\/j.ejps.2018.04.015_bb0035","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.015_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.04.015_bb0045","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-199550040-00007","article-title":"Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients","volume":"50","author":"Goa","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2018.04.015_bb0050","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.33.9.1544","article-title":"Therapeutic evaluation of free and liposome encapsulated amphotericine B in the treatment of systemic candidiasis in mice","volume":"33","author":"Gondal","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2018.04.015_bb0060","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/anie.200502113","article-title":"Polymer therapeutics: concepts and applications","volume":"45","author":"Haag","year":"2006","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejps.2018.04.015_bb0065","first-page":"2433","article-title":"Novel preparation method for sustained-release PLGA microspheres using water-in-oil-inhydrophilic-oil-in-water emulsion","volume":"8","author":"Hong","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.04.015_bb0070","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/pds.2630020406","article-title":"PEM report number 3-fluconazole","volume":"2","author":"Inman","year":"1993","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejps.2018.04.015_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1023\/A:1018980020506","article-title":"The preparation and characterization of PLGA microspheres: II. The entrapment of model protein using (water in oil) in water emulsion solvent evaporation technique","volume":"10","author":"Jeffery","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.015_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3\u20134","key":"10.1016\/j.ejps.2018.04.015_bb0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejps.2006.05.008","article-title":"Preparing and evaluating delivery systems for proteins","volume":"29","author":"Jorgensen","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.015_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejps.2014.05.027","article-title":"Development of recombinant human growth hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase\/aqueous phase emulsion method","volume":"62","author":"Kang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2018.04.015_bb0100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11745-012-3707-9","article-title":"Synthesis and characterization of novel n-9 fatty acid conjugates possessing antineoplastic properties","volume":"47","author":"Khan","year":"2012","journal-title":"Lipids"},{"issue":"5","key":"10.1016\/j.ejps.2018.04.015_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/1061186X.2012.685474","article-title":"Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB\/c mice","volume":"20","author":"Khan","year":"2012","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.ejps.2018.04.015_bb0110","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2217\/nnm.12.166","article-title":"Anticancer efficacy of novel propofol-linoleic acid loaded escheriosomal formulation against murine hepatocellular carcinoma","volume":"8","author":"Khan","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2018.04.015_bb0115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bjid.2016.04.006","article-title":"Antifungal efficacy of amphotericin B encapsulated fibrin microsphere in treatment against Cryptococcus neoformans infection in Swiss albino mice","volume":"20","author":"Khan","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejps.2018.04.015_bb0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejps.2004.07.011","article-title":"Albumin loaded microsphere of amphiphilic poly(ethylene glycol)\/poly(_-ester) multiblock copolymer","volume":"23","author":"Kim","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.015_bb0125","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.40.8.1935","article-title":"Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules","volume":"40","author":"Koks","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0130","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-103-4-533","article-title":"Cryptococcosis in the acquired immunodeficiency syndrome","volume":"103","author":"Kovacs","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2018.04.015_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.04.015_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for the treatment of cryptococcal meningitis: a prospective randomized trial in patients with AIDS","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2018.04.015_bb0145","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2018.04.015_bb0150","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1086\/340525","article-title":"Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus","volume":"34","author":"Liliang","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.04.015_bb0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/jac\/43.6.817","article-title":"Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing","volume":"43","author":"Lortholary","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0160","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/AAC.43.12.2841","article-title":"Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans","volume":"43","author":"Louie","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejps.2018.04.015_bb0165","first-page":"13","article-title":"Protein release from poly (lactic-co-glycolic acid) microspheres: protein stability problems","volume":"49","author":"Lu","year":"1995","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ejps.2018.04.015_bb0170","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/AAC.48.12.4911-4914.2004","article-title":"Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection","author":"MacCallum","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0180","first-page":"267","article-title":"A novel microencapsulated peptide vaccine against hepatitis B. Vaccine.19, 3292-3300","volume":"40","author":"Moynihan","year":"2001","journal-title":"Mycoses"},{"key":"10.1016\/j.ejps.2018.04.015_bb0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.04.015_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/18.2.261","article-title":"Treatment of cryptococcal meningitis in mice with fluconazole","volume":"18","author":"Palou de Fernandez","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejps.2018.04.015_bb0200","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1093\/clinids\/12.Supplement_3.S299","article-title":"Fluconazole therapy for experimental cryptococcosis and candidiasis in the rabbit","volume":"12","author":"Perfect","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.04.015_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejps.2018.04.015_bb0210","first-page":"70","article-title":"Sustained-release polylactide-co-glycolide microspheres loaded with pre-formulated protein polysaccharide nanoparticles","volume":"6","author":"Ren","year":"2011","journal-title":"MicroNano Lett."},{"key":"10.1016\/j.ejps.2018.04.015_bb0215","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease","volume":"30","author":"Saag","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.04.015_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000239592","article-title":"Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group","volume":"43","author":"Stevens","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejps.2018.04.015_bb0225","doi-asserted-by":"crossref","first-page":"S338","DOI":"10.1093\/clinids\/12.Supplement_3.S338","article-title":"Overview: treatment of cryptococcal meningitis","volume":"12","author":"Sugar","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.04.015_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/15583720701455079","article-title":"Anticancer polymeric nanomedicines","volume":"47","author":"Tong","year":"2007","journal-title":"Polym. Rev."},{"key":"10.1016\/j.ejps.2018.04.015_bb0235","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/32.5.723","article-title":"Efficacies of amphotericin-B-desoxycholate liposomal amphotericin-B and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice","volume":"32","author":"Van Etten","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.04.015_bb0240","first-page":"341","article-title":"Levodopa\/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA lesioned rats","volume":"6","author":"Yang","year":"2012","journal-title":"Drug Design, Dev. Ther."},{"key":"10.1016\/j.ejps.2018.04.015_bb0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/IJN.S27621","article-title":"Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres","volume":"7","author":"Yuan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2018.04.015_bb0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejps.2008.08.009","article-title":"Development of protein delivery microsphere system by a novel S\/O\/O\/W multi-emulsion","volume":"36","author":"Yuan","year":"2009","journal-title":"E. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.04.015_bb0255","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.colsurfb.2010.04.004","article-title":"Preparation of protein-loaded sustained-release microspheres via \u2018solid-in-oil-in-hydrophilic oil-in-ethanol (S\/O\/hO\/E)\u2019 emulsification","volume":"79","author":"Yuan","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.04.015_bb0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.04.051","article-title":"Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran\/PLGA\u2013PLA core\/shell microspheres","volume":"450","author":"Zhao","year":"2013","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871830174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871830174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T15:35:05Z","timestamp":1751556905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871830174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":51,"alternative-id":["S092809871830174X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}